Heska (HSKA) Risk Assessment

View and export this data going back to 1997. Start your Free Trial

What is Heska Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Heska is: No Data: Cannot be evaluated.

Competitive Comparison of Heska's Risk Assessment

For the Medical Devices subindustry, Heska's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Heska's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heska's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Heska's Risk Assessment falls into.

Heska (NAS:HSKA) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Heska Risk Assessment Related Terms

Thank you for viewing the detailed overview of Heska's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Heska (HSKA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heska Corp (NAS:HSKA) » Definitions » Risk Assessment

Comparable Companies

AHCO SILK AVNS UFPT FNA PRCT SIBN CTKB OM TMCI ABT MDT SYK BSX EW SZSE:300760 DXCM ZBH ALGN STE

Traded in Other Exchanges

N/A

Address

3760 Rocky Mountain Avenue, Loveland, CO, USA, 80538

Website

https://www.heska.com

Heska Corp is engaged in developing, manufacturing, marketing, selling, and supporting veterinary products. The company's products include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products; and practice information management software and related software. It operates through two segments North America and International. The Company's core strategic focus on Point of Care laboratory and imaging products is included in both segments.

Executives

Joachim A. Hasenmaier	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Robert L Antin	director
Mark F Furlong	director	770 M WATER ST, MILWAUKEE WI 53202
Stephen L Davis	director	2901 BUTTERFIELD ROAD, OAK BROOK IL 60523
Providenti Anthony C. Jr.	officer: EVP, Corporate Development	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Kevin S. Wilson	officer: President and COO	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Eleanor F. Baker	officer: EVP, Managing Dir. & COO, scil	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Christopher D. Sveen	officer: CAO & General Counsel	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Nancy Wisnewski	officer: EVP, Prod. Dev. & Cust. Supp	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Sharon L. Riley	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Catherine Grassman	officer: EVP, CFO	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jason D Aroesty	officer: EVP, International Diagnostics	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Bonnie J. Trowbridge	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Scott Humphrey	director	3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO 80538
Jason A Napolitano	officer: Exec. VP, CFO & Secretary	1613 PROSPECT PARKWAY, FORT COLLINS CO 80525